PACLIALL

Pacliall 100 mg Injection is a chemotherapy medication specifically formulated to combat various forms of cancer, including breast cancer, non-small cell lung cancer, and ovarian cancer. It is also used in certain cases involving AIDS-related complications. By targeting rapidly dividing cancer cells, this medication disrupts their ability to grow and multiply, ultimately slowing down or halting the progression of the disease. Depending on the case, it may be used as a standalone treatment or in combination with other cancer-fighting drugs for a more comprehensive therapeutic approach.

However, this treatment is not suitable for individuals with severe liver dysfunction, active infections, or critically low levels of white blood cells or platelets, as it could worsen these conditions. It is also not advised for individuals under 18 years of age. Prior to starting the therapy, patients with a history of heart disease should inform their healthcare provider, as the drug may impact cardiovascular function.

Since Pacliall 100 mg Injection contains alcohol, it may pose additional risks for patients with a history of alcoholism, and caution is essential. Due to its potential to cause significant allergic reactions, administration is usually carried out under close medical supervision. Additionally, women undergoing treatment are strongly advised to use effective contraception during the course and for six months following the final dose, as the drug can adversely affect fetal development.